NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 21 10:21AM ET
84.75
Dollar change
-1.62
Percentage change
-1.88
%
IndexS&P 500 P/E25.76 EPS (ttm)3.29 Insider Own0.17% Shs Outstand1.28B Perf Week0.59%
Market Cap108.70B Forward P/E13.49 EPS next Y6.28 Insider Trans-1.01% Shs Float1.28B Perf Month1.66%
Income4.26B PEG3.48 EPS next Q1.32 Inst Own85.99% Short Float0.96% Perf Quarter-3.63%
Sales33.20B P/S3.27 EPS this Y5.99% Inst Trans2.99% Short Ratio1.63 Perf Half Y-3.18%
Book/sh38.49 P/B2.20 EPS next Y7.93% ROA4.71% Short Interest12.24M Perf Year-1.36%
Cash/sh6.18 P/C13.72 EPS next 5Y7.41% ROE8.42% 52W Range75.96 - 96.25 Perf YTD6.10%
Dividend Est.2.81 (3.31%) P/FCF19.88 EPS past 5Y-4.12% ROI5.81% 52W High-11.95% Beta0.82
Dividend TTM2.80 (3.30%) Quick Ratio1.43 Sales past 5Y2.89% Gross Margin60.32% 52W Low11.57% ATR (14)1.80
Dividend Ex-DateMar 28, 2025 Current Ratio1.90 EPS Y/Y TTM4.48% Oper. Margin18.65% RSI (14)48.61 Volatility1.39% 1.62%
Employees95000 Debt/Eq0.54 Sales Y/Y TTM2.72% Profit Margin12.83% Recom2.33 Target Price95.35
Option/ShortYes / Yes LT Debt/Eq0.49 EPS Q/Q1.35% Payout99.87% Rel Volume2.66 Prev Close86.37
Sales Surprise1.29% EPS Surprise2.60% Sales Q/Q2.51% EarningsMay 21 BMO Avg Volume7.52M Price84.75
SMA200.17% SMA50-1.59% SMA200-2.80% Trades Volume3,485,747 Change-1.88%
Date Action Analyst Rating Change Price Target Change
Mar-04-25Upgrade Citigroup Neutral → Buy $92 → $107
Oct-10-24Upgrade RBC Capital Mkts Sector Perform → Outperform $98 → $105
Aug-21-24Reiterated Oppenheimer Perform $92 → $94
Aug-15-24Upgrade UBS Sell → Neutral $76 → $90
Aug-14-24Downgrade Stifel Buy → Hold $100 → $85
May-30-24Initiated Goldman Sell $83
Jul-19-23Initiated Robert W. Baird Neutral $90
Jun-30-23Initiated CL King Buy $106
May-30-23Upgrade Morgan Stanley Equal-Weight → Overweight $104
Apr-24-23Upgrade Wells Fargo Equal Weight → Overweight $77 → $100
Today 09:39AM
09:30AM
09:10AM
08:51AM
07:55AM
07:39AM Loading…
07:39AM
07:04AM
06:45AM
06:44AM
05:18AM
May-20-25 02:53PM
May-18-25 12:05PM
05:00AM
May-16-25 10:00AM
09:15AM
08:36AM Loading…
08:36AM
07:47AM
May-15-25 08:15PM
06:49AM
May-14-25 05:45PM
10:25AM
May-13-25 04:43PM
May-12-25 05:10PM
04:28PM
May-10-25 08:21AM
May-09-25 06:35AM
May-08-25 05:45PM
03:00PM
07:45AM
07:20AM
06:07PM Loading…
May-07-25 06:07PM
03:00PM
10:02AM
May-03-25 09:45AM
May-02-25 05:45PM
Apr-30-25 05:50PM
08:30AM
05:38AM
Apr-29-25 09:30PM
08:07PM
12:30PM
11:10AM
Apr-28-25 11:25PM
07:26AM
07:15AM
05:27AM
Apr-26-25 07:20PM
02:32PM
02:20PM
Apr-25-25 05:45PM
03:00PM
12:26PM
06:09AM
03:09AM
Apr-24-25 05:45PM
11:50AM
09:00AM
Apr-23-25 05:50PM
11:00AM
09:00AM
03:23AM
Apr-22-25 10:09AM
08:30AM
07:00AM
Apr-21-25 03:21PM
01:15PM
10:30AM
07:52AM
07:20AM
05:12AM
Apr-18-25 07:00PM
Apr-17-25 05:50PM
02:00PM
08:10AM
Apr-16-25 05:02PM
04:56PM
08:45AM
Apr-15-25 12:26PM
07:22AM
05:41AM
Apr-14-25 08:30AM
Apr-11-25 05:50PM
04:20AM
Apr-10-25 09:34AM
Apr-09-25 03:21AM
Apr-07-25 08:48AM
Apr-06-25 12:54AM
Apr-03-25 05:45PM
02:23PM
10:38AM
10:29AM
05:37AM
Apr-02-25 05:50PM
06:00AM
Apr-01-25 10:36AM
07:25AM
06:30AM
06:12AM
Mar-31-25 06:11PM
04:21PM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walter Matthew R.SVP, Chief HR OfficerJan 27 '25Option Exercise74.841,337100,06126,997Jan 28 05:10 PM
Marinaro MichaelEVP & President, Surgical OUJan 27 '25Option Exercise74.842,345175,50043,323Jan 28 05:09 PM
Martha GeoffreyChairman and CEOJan 27 '25Option Exercise74.8434,7412,600,016216,954Jan 28 05:07 PM
Wall Brett A.EVP & Pres NeuroscienceJan 24 '25Option Exercise78.0012,437970,08653,416Jan 27 05:35 PM
Wall Brett A.EVP & Pres NeuroscienceJan 24 '25Sale90.0012,4371,119,33040,979Jan 27 05:35 PM
Wall Brett A.OfficerJan 24 '25Proposed Sale90.0012,4371,119,330Jan 24 02:34 PM
Wall Brett A.EVP & Pres NeuroscienceJan 08 '25Option Exercise74.846,850512,65450,558Jan 10 04:48 PM
Wall Brett A.EVP & Pres NeuroscienceJan 08 '25Sale80.419,850792,03840,708Jan 10 04:48 PM
Wall Brett A.OfficerJan 08 '25Proposed Sale80.419,850792,038Jan 08 09:52 AM
PARKHILL KAREN LFormer DirectorOct 31 '24Proposed Sale89.7330,0002,691,794Oct 31 03:21 PM
PARKHILL KAREN LFormer DirectorOct 30 '24Proposed Sale90.5815,0001,358,740Oct 30 04:11 PM
PARKHILL KAREN LFormer BODOct 29 '24Proposed Sale91.1615,0001,367,348Oct 29 03:26 PM
PARKHILL KAREN LFormer DirectorOct 24 '24Proposed Sale92.4922,7122,100,633Oct 24 04:01 PM
PARKHILL KAREN LFormer DirectorOct 23 '24Proposed Sale91.7623,8482,188,205Oct 23 04:30 PM
PARKHILL KAREN LFormer BODOct 18 '24Proposed Sale91.7448,8254,479,310Oct 18 04:24 PM
PARKHILL KAREN LFormer BODOct 17 '24Proposed Sale89.8755,1794,958,718Oct 17 03:35 PM
PARKHILL KAREN LFormer OfficerAug 26 '24Proposed Sale90.002,668240,120Aug 26 02:11 PM
Wall Brett A.EVP & Pres NeuroscienceAug 02 '24Option Exercise0.005,311049,169Aug 06 06:16 PM
Walter Matthew R.SVP, Chief HR OfficerAug 02 '24Option Exercise0.00684025,889Aug 06 06:15 PM
Smith Gregory LEVP Global Ops & Supply ChainAug 02 '24Option Exercise0.003,490064,757Aug 06 06:14 PM
Salmon SeanEVP & President CardiovascularAug 02 '24Option Exercise0.005,462068,546Aug 06 06:14 PM
PARKHILL KAREN LEVP & Chief Financial OfficerAug 02 '24Option Exercise0.007,132053,459Aug 06 06:13 PM
Martha GeoffreyChairman and CEOAug 02 '24Option Exercise0.0018,9660203,086Aug 06 06:13 PM
Marinaro MichaelEVP & President, Surgical OUAug 02 '24Option Exercise0.001,670043,801Aug 06 06:12 PM
Kirk Jennifer MChief Accounting OfficerAug 02 '24Option Exercise0.001,138028,980Aug 06 06:12 PM
Fong Ivan KEVP GENERAL COUNSEL & SECRAug 02 '24Option Exercise0.0014,514063,750Aug 06 06:11 PM
Walter Matthew R.SVP, Chief HR OfficerJul 18 '24Option Exercise62.7649230,87817,580Jul 19 04:40 PM
Martha GeoffreyChairman and CEOJun 07 '24Option Exercise62.7619,1131,199,532162,461Jun 11 06:53 PM
Martha GeoffreyChairman and CEOJun 07 '24Sale83.7719,1131,601,001143,348Jun 11 06:53 PM